Figure 2.
OS and PFS by ALK status. End-of-study (A) OS and (B) PFS were comparable among patients with ALK+ and ALK– systemic ALCL.
OS and PFS by ALK status. End-of-study (A) OS and (B) PFS were comparable among patients with ALK+ and ALK– systemic ALCL.
